短期低剂量托尔瓦普坦治疗严重低血量症的有效性和肝脏安全性:一项追溯比较研究
Seyit Uyar1, Müberra Kaplan Çayir1, Nizameddin Koca2
1Department of Internal Medicine, University of Health Sciences, Antalya Training and Research Hospital, Antalya, Turkey.
Medicine
|August 19, 2025
概括
短期的低剂量托尔瓦普坦有效地治疗住院患者的严重低血症. 这项研究发现它对肝功能是安全的,即使在先前存在的酶升高的情况下,也提供了切实可行的替代方案.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 肝病学 肝病学是一种肝病学.
- 内部医学 内部医学
背景情况:
- 托尔瓦普坦在低血症中有效,但存在对长期使用高剂量的肝毒性在自身主导性多囊性病中存在担忧.
- 这限制了其更广泛的临床应用.
研究的目的:
- 为了评估短期低剂量托尔瓦普坦的疗效和肝脏安全性,与严重低血症住院患者的3%高血压盐水相比.
- 评估对患者肝功能测试的影响,患者肝酶基线正常和升高.
主要方法:
- 对236名患有严重低血症 (血清<125mEq/L) 的住院成年人进行了回顾性评估.
- 118名患者接受了口服托尔瓦普坦 (15毫克/天4天以上);118名患者接受了3%的高血压盐水.
- 随着时间的推移,血清,,BUN,肌和肝功能测试 (AST,ALT, bilirubin) 的分析.
主要成果:
- 这两组都显示出血清含量显著增加 (P < .001).
- 托尔瓦普坦组在24小时和72小时内含量较高 (P = .042).
- 没有观察到临床明显的肝毒性;在正常基线组中,暂时的,无意义的AST/ALT波动;在高基线组中,AST/bilirubin改善.
结论:
- 短期,低剂量托尔瓦普坦有效地纠正严重的低血症.
- 它表现出良好的肝安全性,即使在患有基线肝酶升高的患者中也是如此.
- 托尔瓦普坦是一种安全和实用的治疗选择,用于选择患有严重低血症的住院患者.
相关概念视频
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
761
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
761
01:11Renal Failure: Dose Adjustments
153
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
153
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:22Acute Kidney Injury VI: Nursing Management
57
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
57
01:28Renal Drug Excretion: Tubular Secretion
355
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
355
01:22Heart Failure Drugs: Diuretics
483
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
483